RESUMEN
Obesity and type 2 diabetes are associated with disturbances in insulin-regulated glucose and lipid fluxes and severe comorbidities including cardiovascular disease and steatohepatitis. Whole body metabolism is regulated by lipid-storing white adipocytes as well as "brown" and "brite/beige" adipocytes that express thermogenic uncoupling protein 1 (UCP1) and secrete factors favorable to metabolic health. Implantation of brown fat into obese mice improves glucose tolerance, but translation to humans has been stymied by low abundance of primary human beige adipocytes. Here we apply methods to greatly expand human adipocyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermogenic suppressor gene NRIP1 by CRISPR. Ribonucleoprotein consisting of Cas9 and sgRNA delivered ex vivo are fully degraded by the human cells following high efficiency NRIP1 depletion without detectable off-target editing. Implantation of such CRISPR-enhanced human or mouse brown-like adipocytes into high fat diet fed mice decreases adiposity and liver triglycerides while enhancing glucose tolerance compared to implantation with unmodified adipocytes. These findings advance a therapeutic strategy to improve metabolic homeostasis through CRISPR-based genetic enhancement of human adipocytes without exposing the recipient to immunogenic Cas9 or delivery vectors.
Asunto(s)
Adipocitos Marrones/trasplante , Sistemas CRISPR-Cas/genética , Intolerancia a la Glucosa/terapia , Obesidad/terapia , Termogénesis/genética , Adipocitos Marrones/metabolismo , Adipocitos Blancos/metabolismo , Células Madre Adultas/fisiología , Animales , Técnicas de Cultivo de Célula/métodos , Diferenciación Celular , Dieta Alta en Grasa/efectos adversos , Modelos Animales de Enfermedad , Hígado Graso/etiología , Hígado Graso/metabolismo , Hígado Graso/prevención & control , Edición Génica/métodos , Intolerancia a la Glucosa/etiología , Intolerancia a la Glucosa/metabolismo , Humanos , Metabolismo de los Lípidos/genética , Masculino , Ratones , Proteína de Interacción con Receptores Nucleares 1/genética , Proteína de Interacción con Receptores Nucleares 1/metabolismo , Obesidad/complicaciones , Obesidad/metabolismo , ARN Guía de Kinetoplastida/genética , Grasa Subcutánea/citologíaAsunto(s)
Adipocitos Marrones/fisiología , Glucógeno/metabolismo , Gotas Lipídicas/metabolismo , Metabolismo de los Lípidos/fisiología , Adipocitos Marrones/trasplante , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Pardo/fisiología , Tejido Adiposo Pardo/trasplante , Animales , Diferenciación Celular , Metabolismo Energético/fisiología , Humanos , Enfermedades Metabólicas/metabolismo , Enfermedades Metabólicas/terapiaRESUMEN
The discovery of brown fat in adult humans has led to increased research of the thermogenic function of this tissue in various metabolic diseases. In addition, high levels of brown fat have been correlated with lower body mass index values. Therefore, increasing brown fat mass and/or activity through methods such as the browning of white fat is considered a promising strategy to prevent and treat obesity-associated diseases. Cell-based approaches using mesenchymal stromal cells and brown adipose tissue (BAT) have been utilized to directly increase BAT mass/activity through cell and tissue implantation into animals. In addition, recent studies evaluating the transplantation of human embryonic stem cells and induced pluripotent stem (iPS) cells have shown promising results in terms of positive metabolic function. In this comprehensive review, we provide a summary of the research over the past 10 years with regard to stem cell therapy and brown fat tissue transplantation for the effective treatment of metabolic syndrome. Recent advancements in stem cell methods have allowed for the production of brown adipocytes from human iPS cells, which represent an unlimited source of cellular material with which to study adipocyte development. In addition, this process is expected to be used to further explore drug- and cell-based therapies to treat obesity-related metabolic complications.
Asunto(s)
Tejido Adiposo Pardo/trasplante , Enfermedades Metabólicas/terapia , Trasplante de Células Madre , Adipocitos Marrones/trasplante , Tejido Adiposo Pardo/metabolismo , Animales , Exosomas/metabolismo , Humanos , Células Madre Pluripotentes Inducidas/metabolismoRESUMEN
Rheumatoid arthritis (RA) is a systemic autoimmune disease involving excessive inflammation. Recently, RA associated with a metabolic disorder was revealed to be non-responsive to RA medications. Metformin has been reported to have a therapeutic effect on RA and obesity. The aim of this investigation was to study the therapeutic effect and the underlying mechanism of metformin's action in an experimental model of collagen-induced arthritis (CIA) associated with obesity. Metformin was administered daily for 13 weeks to mice with CIA that had been fed a high-fat diet. Metformin ameliorated the development of CIA in obese mice by reducing autoantibody expression and joint inflammation. Furthermore, metformin decreased the expression levels of pSTAT3 and pmTOR and had a small normalizing effect on the metabolic profile of obese CIA mice. In addition, metformin increased the production of pAMPK and FGF21. Metformin also induced the differentiation of brown adipose tissue (BAT), which led to a reciprocal balance between T helper (Th) 17 and regulatory T (Treg) cells in vitro and in vivo. These results suggest that metformin can dampen the development of CIA in obese mice and reduce metabolic dysfunction by inducing BAT differentiation. Thus, metformin could be a therapeutic candidate for non-responsive RA.
Asunto(s)
Adipocitos Marrones/efectos de los fármacos , Antiinflamatorios no Esteroideos/farmacología , Artritis Reumatoide/tratamiento farmacológico , Factores de Crecimiento de Fibroblastos/genética , Metformina/farmacología , Obesidad/complicaciones , Adipocitos Marrones/patología , Adipocitos Marrones/trasplante , Animales , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/genética , Artritis Experimental/patología , Artritis Reumatoide/etiología , Artritis Reumatoide/patología , Diferenciación Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Ratones Endogámicos DBA , Factor de Transcripción STAT3/metabolismo , Linfocitos T Reguladores/efectos de los fármacos , Células Th17/efectos de los fármacosRESUMEN
Obesity is a leading health problem facing the modern world; however, no effective therapy for this health issue has yet been developed. A promising research direction to identify novel therapies to prevent obesity has emerged from discoveries on development and function of brown/brite adipocytes in mammals. Importantly, there is evidence for the presence and function of active thermogenic brown adipocytes in both infants and adult humans. Several new investigations have shown that thermogenic adipocytes are beneficial to maintain glucose homeostasis, insulin sensitivity, and a healthy body fat content. Such thermogenic adipocytes have been considered as targets to develop a therapy for preventing obesity. This short review seeks to highlight recent findings on the development and function of brown/brite adipocytes in humans and to discuss potential treatments based on these adipocytes to reduce obesity and its related disorders.
Asunto(s)
Adipocitos Beige/metabolismo , Adipocitos Marrones/metabolismo , Adipogénesis , Modelos Biológicos , Termogénesis , Adipocitos Beige/citología , Adipocitos Beige/patología , Adipocitos Beige/trasplante , Adipocitos Marrones/citología , Adipocitos Marrones/patología , Adipocitos Marrones/trasplante , Adipocitos Blancos/citología , Adipocitos Blancos/metabolismo , Adipocitos Blancos/patología , Adiposidad , Animales , Capilares/citología , Humanos , Resistencia a la Insulina , Obesidad/metabolismo , Obesidad/patología , Obesidad/prevención & control , Células del Estroma/citologíaRESUMEN
Uncoupling protein 1 (UCP1) is highly expressed in brown adipose tissue, where it generates heat by uncoupling electron transport from ATP production. UCP1 is also found outside classical brown adipose tissue depots, in adipocytes that are termed 'brite' (brown-in-white) or 'beige'. In humans, the presence of brite or beige (brite/beige) adipocytes is correlated with a lean, metabolically healthy phenotype, but whether a causal relationship exists is not clear. Here we report that human brite/beige adipocyte progenitors proliferate in response to pro-angiogenic factors, in association with expanding capillary networks. Adipocytes formed from these progenitors transform in response to adenylate cyclase activation from being UCP1 negative to being UCP1 positive, which is a defining feature of the beige/brite phenotype, while displaying uncoupled respiration. When implanted into normal chow-fed, or into high-fat diet (HFD)-fed, glucose-intolerant NOD-scid IL2rg(null) (NSG) mice, brite/beige adipocytes activated in vitro enhance systemic glucose tolerance. These adipocytes express neuroendocrine and secreted factors, including the pro-protein convertase PCSK1, which is strongly associated with human obesity. Pro-angiogenic conditions therefore drive the proliferation of human beige/brite adipocyte progenitors, and activated beige/brite adipocytes can affect systemic glucose homeostasis, potentially through a neuroendocrine mechanism.
Asunto(s)
Adipocitos/metabolismo , Glucemia/metabolismo , Intolerancia a la Glucosa/metabolismo , Neovascularización Fisiológica , Consumo de Oxígeno , ARN Mensajero/metabolismo , Adipocitos/trasplante , Adipocitos Marrones/metabolismo , Adipocitos Marrones/trasplante , Adipocitos Blancos/metabolismo , Adipocitos Blancos/trasplante , Adulto , Anciano , Animales , Proteínas Reguladoras de la Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/metabolismo , Capilares , Trasplante de Células , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Dieta Alta en Grasa , Encefalinas/genética , Encefalinas/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Técnica de Clampeo de la Glucosa , Prueba de Tolerancia a la Glucosa , Homeostasis , Humanos , Integrina beta1/genética , Integrina beta1/metabolismo , Interleucina-33/genética , Interleucina-33/metabolismo , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/metabolismo , Canales Iónicos/genética , Canales Iónicos/metabolismo , Masculino , Ratones , Persona de Mediana Edad , Proteínas Mitocondriales/genética , Proteínas Mitocondriales/metabolismo , Obesidad/metabolismo , Reacción en Cadena de la Polimerasa , Proproteína Convertasa 1/genética , Proproteína Convertasa 1/metabolismo , Precursores de Proteínas/genética , Precursores de Proteínas/metabolismo , Proteínas , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/genética , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/metabolismo , Proteína Desacopladora 1 , Yodotironina Deyodinasa Tipo IIRESUMEN
Brown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism. Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs resulting in therapeutic benefit. Here, we show generation of functional BAs by cellular reprogramming procedures. Transduction of the PRDM16 gene into iPSC-derived embryoid bodies induced BA phenotypes (iBAs). Moreover, normal human fibroblasts were directly converted into BAs (dBAs) by C/EBP-ß and C-MYC gene transduction. Approximately 90% of the fibroblasts were successfully converted within 12 days. The dBAs were highly active in mitochondrial biogenesis and oxidative metabolism. Mouse dBAs were induced by Prdm16, C/ebp-ß, and L-myc genes, and after transplantation, they significantly reduced diet-induced obesity and insulin resistance in an UCP1-dependent manner. Thus, highly functional BAs can be generated by cellular reprogramming, suggesting a promising tailor-made cell therapy against metabolic disorders including type 2 diabetes mellitus.
Asunto(s)
Adipocitos Marrones/citología , Adipocitos Marrones/trasplante , Reprogramación Celular , Diabetes Mellitus Tipo 2/terapia , Dislipidemias/terapia , Resistencia a la Insulina , Obesidad/terapia , Adipocitos Marrones/metabolismo , Animales , Línea Celular , Proteínas de Unión al ADN/genética , Dieta Alta en Grasa/efectos adversos , Fibroblastos/citología , Fibroblastos/metabolismo , Humanos , Células Madre Pluripotentes Inducidas/citología , Células Madre Pluripotentes Inducidas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Factores de Transcripción/genética , Transducción GenéticaRESUMEN
The factors contributing to heterotopic ossification, the formation of bone in abnormal soft-tissue locations, are beginning to emerge, but little is known about microenvironmental conditions promoting this often devastating disease. Using a murine model in which endochondral bone formation is triggered in muscle by bone morphogenetic protein 2 (BMP2), we studied changes near the site of injection of BMP2-expressing cells. As early as 24 hours later, brown adipocytes began accumulating in the lesional area. These cells stained positively for pimonidazole and therefore generated hypoxic stress within the target tissue, a prerequisite for the differentiation of stem cells to chondrocytes and subsequent heterotopic bone formation. We propose that aberrant expression of BMPs in soft tissue stimulates production of brown adipocytes, which drive the early steps of heterotopic endochondral ossification by lowering oxygen tension in adjacent tissue, creating the correct environment for chondrogenesis. Results in misty gray lean mutant mice not producing brown fat suggest that white adipocytes convert into fat-oxidizing cells when brown adipocytes are unavailable, providing a compensatory mechanism for generation of a hypoxic microenvironment. Manipulation of the transcriptional control of adipocyte fate in local soft-tissue environments may offer a means to prevent or treat development of bone in extraskeletal sites.